These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 27865894)
1. Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects. Pseftogas A; Gonidas C; Mosialos G Int J Biochem Cell Biol; 2017 Jan; 82():49-56. PubMed ID: 27865894 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A. Olsen H; Haldosén LA Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014 [TBL] [Abstract][Full Text] [Related]
4. Effect of troglitazone on CYP1A1 induction. Kim HG; Han EH; Jeong HG Toxicology; 2008 Apr; 246(2-3):166-71. PubMed ID: 18308446 [TBL] [Abstract][Full Text] [Related]
5. Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms. Chuang CH; Yeh CL; Yeh SL; Lin ES; Wang LY; Wang YH J Nutr Biochem; 2016 Jul; 33():45-53. PubMed ID: 27260467 [TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072 [TBL] [Abstract][Full Text] [Related]
7. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. Baek SJ; Wilson LC; Hsi LC; Eling TE J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986 [TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor. Gras D; Chanez P; Urbach V; Vachier I; Godard P; Bonnans C Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L970-8. PubMed ID: 19346435 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743 [TBL] [Abstract][Full Text] [Related]
10. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells. Colin-Cassin C; Yao X; Cerella C; Chbicheb S; Kuntz S; Mazerbourg S; Boisbrun M; Chapleur Y; Diederich M; Flament S; Grillier-Vuissoz I Mol Carcinog; 2015 May; 54(5):393-404. PubMed ID: 24293218 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1. Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607 [TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790 [TBL] [Abstract][Full Text] [Related]
14. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. Pandhare J; Cooper SK; Phang JM J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758 [TBL] [Abstract][Full Text] [Related]
15. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth. Pon CK; Firth SM; Baxter RC Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421 [TBL] [Abstract][Full Text] [Related]
16. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751 [TBL] [Abstract][Full Text] [Related]
17. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Krönke G; Kadl A; Ikonomu E; Blüml S; Fürnkranz A; Sarembock IJ; Bochkov VN; Exner M; Binder BR; Leitinger N Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1276-82. PubMed ID: 17413033 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431 [TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance. Skildum A; Dornfeld K; Wallace K Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]